MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Resting-state network reorganization following multimodal lifestyle intervention in Parkinson’s disease

    A. Aali, J. Kelly, M. Powell, R. Cloke, A. Hashimoto, Y. Wang, A. Kuan, D. Darabi, T. Watson, J. Yu, S. Dhaliwal, K. Pressman-Cyna, M. Williams, M. Paventi, R. Hassen, O. Brigden, J. Stoessl, V. Sossi, M. Mckeown, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To investigate longitudinal changes in resting-state (rs) functional connectivity following a multimodal lifestyle intervention in individuals with Parkinson's disease (PD). Background: PD is associated with disruption of large-scale…
  • 2026 International Congress

    Phenotypic and Genotypic Spectrum of MAPT-associated Parkinsonism in a Multi-ethnic Malaysian Cohort

    JP. Schee, YW. Tay, TS. Toh, AN. Khairul Anuar, HX. Ding, JWY. Tee, AL. Lee, A. Ahmad-Annuar, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: To describe the phenotypic continuum and genotypic spectrum of microtubule-associated protein tau (MAPT)-associated parkinsonism in a multi-ethnic Malaysian cohort. Background: Carriers of pathogenic MAPT…
  • 2026 International Congress

    Variants in Cytochrome P450–encoding Genes Associated with Parkinson’s Disease

    N. Kanzato, K. Nakachi, Y. Namihira, H. Matumoto, F. Kinjyo, T. Oguro (Haebaru-cho, Okinawa, Japan)

    Objective: To characterize the clinical features of PD associated with CYP gene variants (CYP‑iPD) and parkinsonism observed in other neurodegenerative diseases. Background: Cytochrome P450 (CYP)…
  • 2026 International Congress

    The Lived Experience of Parkinson’s Disease in the Philippines: Challenges, Cultural Constructs, and Caregiving Impacts

    FM. Lawas, GS. Saranza, JH. Hernani (Cebu, Philippines)

    Objective: This study aims to explore the lived experiences of PD patients and their caregivers in Cebu Province, Philippines; identify psychosocial and healthcare-related challenges; assess…
  • 2026 International Congress

    Neurofilament Light Chain as a Prognostic Marker of Motor Progression in Parkinson’s Disease: A Systematic Review

    M. Sabharwal, D. Dash, A. Elavarasi, (London, Canada)

    Objective: To identify systematically  studies evaluating CSF, serum, and plasma NfL as a prognostic factor for clinical progression in PD and  to describe study characteristics…
  • 2026 International Congress

    Multi-Ancestry Analysis of Repeat Expansions in Parkinson’s Disease

    L. Lange, C. Cerquera-Cleves, A. Tan, S. Lim, N. Okubadejo, C. Lin, P. Chen, J. Shin, A. Ahmad-Annuar, C. Klein, H. Leonard, N. Mencacci, M. Nalls, H. Morris, K. Lohmann, C. Blauwendraat, P. Heutink, Z. Fang (Luebeck, Germany)

    Objective: To systematically assess known disease-causing repeat expansions detectable by short-read sequencing in Parkinson’s Disease (PD) and atypical parkinsonism and examine repeat length-disease relationships to…
  • 2026 International Congress

    Clinical outcomes of deep brain stimulation for Parkinson’s disease in the Dominican Republic: results from a newly established single-center DBS program

    W. Massih Montero, M. Espinosa Pérez, A. Segura Peña, V. Torres, A. Carreras, A. Pérez Fernández, K. Del Giudice (Santo Domingo, Dominican Republic)

    Objective: To evaluate motor improvement after bilateral STN-DBS in patients with Parkinson’s disease in the Dominican Republic. Secondary objectives included assessing reduction in dopaminergic medication…
  • 2026 International Congress

    Dopaminergic Medication Changes Following LFP-Guided Deep Brain Stimulation Programming in Parkinson’s Disease: A Single-Centre Audit

    M. Pagan, F. Kotsi, M. Boca (Bristol, United Kingdom)

    Objective: To evaluate changes in levodopa equivalent daily dose (LEDD) following deep brain stimulation (DBS) with local field potential (LFP)-guided programming in patients with Parkinson’s disease.…
  • 2026 International Congress

    Wearable IMU-Based Gait Analysis Reveals Pharmacological Freezing-of-Gait Phenotypes in Parkinson Disease: A Longitudinal Two-Visit Study

    FT. Tokdemi̇r, IK. Barkut, I. Arslan, BN. Tekes, BE. örnek, ş. Yılmaz, B. Altunrende (Beyoğlu, Turkey)

    Objective: TolongitudinallyevaluatewearableIMU-derived gaitparameters across two clinical visits andcharacterizepharmacological responsephenotypes inParkinsondiseasepatientswith freezingof gait (FOG). Background: FOG affects upto 80% of patientswith advanced PD and frequentlydemonstrates absent…
  • 2026 International Congress

    Designing a virtual reality-based rehabilitation therapy for Parkinson disease

    BA. Lopez, RD. Jamora, VM. Anlacan, IT. Salido, BA. Galecio, ME. Aguila, CA. Cruz, D. Cruz, A. Rabano, C. Tee, J. Caro, M. Tee (Manila, Philippines)

    Objective: The study aims to determine design considerations for a virtual reality-based therapy targeting motor disabilities of Parkinson disease (PD) patients. Background: PD has the…
  • « Previous Page
  • 1
  • …
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley